Stay updated on Nivolumab for Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Hematologic Malignancies Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a minor backend/UI release with no visible changes to study data or navigation.
    Difference
    0.1%
    Check dated 2026-03-11T14:39:04.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added site revision note 'Revision: v3.4.2' and removed a funding-status notice; these are minor metadata changes that do not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T09:24:40.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and NIH Clinical Center status was added, and the site version updated to v3.4.1 (replacing v3.4.0). These changes do not modify the study details, enrollment, endpoints, or eligibility for the NCT03146468 study.
    Difference
    0.5%
    Check dated 2026-02-04T05:50:57.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI updates include a new 'Show glossary' option, a revision stamp (v3.4.0), and added notices such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:10:55.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4; no changes to the study details, layout, or user-facing content were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:01:10.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The Locations section now includes Victoria (Parkville, Victoria) as a trial site. The HHS Vulnerability Disclosure footer link was removed and the revision note updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:12:07.000Z thumbnail image

Stay in the know with updates to Nivolumab for Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Hematologic Malignancies Clinical Trial page.